Table 2.
Multivariate analyses using Cox proportional hazard model for 2-year mortality
| Variable | HR | 95% CI | p value |
|---|---|---|---|
| Age | 1.033 | 1.015–1.050 | < 0.001 |
| Male sex | 0.478 | 0.309–0.741 | 0.001 |
| BMI, kg/m2 | 0.962 | 0.898–1.031 | 0.275 |
| Ischemic etiology | 1.191 | 0.770–1.031 | 0.275 |
| NYHA class III–IV | 5.784 | 2.298–14.555 | < 0.001 |
| HTN | 1.304 | 0.818–2.078 | 0.265 |
| DM | 1.588 | 1.036–2.435 | 0.034 |
| β-Blocker | 0.526 | 0.327–0.845 | 0.008 |
| ACEI/ARB | 0.768 | 0.484–1.218 | 0.620 |
| Serum sodium, mmol/L | 1.000 | 0.964–1.038 | 0.998 |
| Serum creatinine, mg/dL | 1.096 | 0.895–1.341 | 0.376 |
| Ln NT-proBNP, pg/mL | 1.220 | 1.006–1.480 | 0.044 |
| Ln CA-125, U/mL | 1.230 | 1.021–1.482 | 0.030 |
HR, hazard ratio; CI, confidence interval; BMI, body mass index; NYHA, New York Heart Association; HTN, hypertension; DM, diabetes mellitus; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; Ln, natural logarithm; NT-proBNP, N-terminal pro-brain natriuretic peptide; CA-125, carbohydrate antigen 125.